1. Home
  2. OLLI vs VRNA Comparison

OLLI vs VRNA Comparison

Compare OLLI & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLLI
  • VRNA
  • Stock Information
  • Founded
  • OLLI 1982
  • VRNA 2005
  • Country
  • OLLI United States
  • VRNA United Kingdom
  • Employees
  • OLLI N/A
  • VRNA N/A
  • Industry
  • OLLI Department/Specialty Retail Stores
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OLLI Consumer Discretionary
  • VRNA Health Care
  • Exchange
  • OLLI Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • OLLI 7.6B
  • VRNA 8.3B
  • IPO Year
  • OLLI 2015
  • VRNA 2017
  • Fundamental
  • Price
  • OLLI $138.04
  • VRNA $105.18
  • Analyst Decision
  • OLLI Buy
  • VRNA Buy
  • Analyst Count
  • OLLI 14
  • VRNA 11
  • Target Price
  • OLLI $126.79
  • VRNA $114.10
  • AVG Volume (30 Days)
  • OLLI 888.7K
  • VRNA 8.2M
  • Earning Date
  • OLLI 08-28-2025
  • VRNA 08-11-2025
  • Dividend Yield
  • OLLI N/A
  • VRNA N/A
  • EPS Growth
  • OLLI 2.49
  • VRNA N/A
  • EPS
  • OLLI 3.25
  • VRNA N/A
  • Revenue
  • OLLI $2,339,654,000.00
  • VRNA $118,535,000.00
  • Revenue This Year
  • OLLI $16.61
  • VRNA $893.95
  • Revenue Next Year
  • OLLI $11.51
  • VRNA $73.76
  • P/E Ratio
  • OLLI $42.47
  • VRNA N/A
  • Revenue Growth
  • OLLI 8.70
  • VRNA N/A
  • 52 Week Low
  • OLLI $86.05
  • VRNA $18.51
  • 52 Week High
  • OLLI $140.25
  • VRNA $105.50
  • Technical
  • Relative Strength Index (RSI)
  • OLLI 63.22
  • VRNA 70.25
  • Support Level
  • OLLI $129.56
  • VRNA $104.58
  • Resistance Level
  • OLLI $140.25
  • VRNA $105.31
  • Average True Range (ATR)
  • OLLI 4.19
  • VRNA 0.22
  • MACD
  • OLLI 0.25
  • VRNA -0.64
  • Stochastic Oscillator
  • OLLI 87.26
  • VRNA 60.49

About OLLI Ollie's Bargain Outlet Holdings Inc.

Ollie's Bargain Outlet Holdings Inc is a retailer of closeout merchandise and excess inventory. The company sells name brand household related items that consumers use in their everyday lives at prices that are heavily discounted below traditional retailers. It offers customers a broad selection of brand name products, including housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns.

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Share on Social Networks: